Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Overview of attention for article published in JACC, January 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 3 news outlets
twitter: 118 X users

patent: 1 patent
facebook: 2 Facebook pages

Readers on

mendeley: 207 Mendeley

Summary News X Patents Facebook

So far, Altmetric has seen 2 public wall posts from 2 users.

JACC Journals - Journals of the American College of Cardiology, 18 Jan 2020

#JACC Editors’ Insights: Lipoprotein(a) (Lp[a]) concentration is associated with CV events. Alirocumab, a PCSK9i inhibitor…

CardioAcademic, 14 Jan 2020

Journal of the American College of…